Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Hacettepe Genetic Diseases Diagnosis Center, |
RCV000684827 | SCV000732903 | likely pathogenic | Spondylo-megaepiphyseal-metaphyseal dysplasia | 2018-03-30 | no assertion criteria provided | clinical testing | The c.507_508delCA (p.Gly171Cysfs*55) in exon 2 (GRCh37, NM_001189.3) of NKX3-2 has not been reported previously in the literature. Index patient was an affected newborn with dysmorphic facial features and severe short trunk. The patient required immediate intubation at the delivery room and duodenal atresia was detected during his course in neonatal intensive care unit. Skeletal survey revealed total absence of ossification of the vertebral bodies, pubes, and ischia. The long bones were short and broad with flared metaphyses. The downward sloping or tented appearance of the ribs were distinctive. A diagnosis of “Spondylo-Megaepiphyseal-Metaphyseal Dysplasia†(SMMD) was made on clinical and radiological grounds. The patient was operated on postnatal day 7 for duodenal atresia. In the post-operative period he developed sepsis and respiratory failure and he died on postnatal day 14. Molecular analysis revealed homozygosity for a novel mutation, c.507_508delCA (p.Gly171Cysfs*55) in exon 2 of NKX3-2. Sanger sequencing revealed that father and mother were both heterozygous carriers for homozygous G171Cfs*55 variant in NKX3-2. This genetic change was predicted as "Disease Causing" by MutationTaster (with the score of 1.0). This genetic change was not present in our in-house database established within “Hacettepe Exome Project†which comprises 380 clinically unrelated Turkish individuals. In summary, the p.Gly171Cysfs*55 variant meets our criteria to be classified as “Likely pathogenicâ€. |
OMIM | RCV000684827 | SCV000898487 | pathogenic | Spondylo-megaepiphyseal-metaphyseal dysplasia | 2019-04-22 | no assertion criteria provided | literature only |